2442 Taib et al.
Asian J. Chem.
2-[3′,5′-Diaminopyrazol-1′-yl]-7H-6-(2′-hydroxy-
d6) δ (ppm): 148, 144, 140 (C=N), 130-125 (aromatic carbons),
68 (-CH-), 42 (CH2 carbon). Analytical data for C29H21N5SO
(487): Calcd.: C, 71.45; H, 4.31; N, 14.45; S, 6.57 %. Found:
C, 71.20; H, 4.11; N, 14.30; S, 6.25 %.
naphthalene)thiazolo[5,4-d]pyrazole (4): Equimolar mixture
of compound 3 (2.97 g, 0.01 mol) and malononitrile (0.66 g,
0.01 mol) in abs. ethanol (100 mL) with piperidine (few drops)
refluxed for 4 h. Cooled and then poured onto ice. The solid
obtained filtered off and crystallized from DMF, to give compound
4, yield (2.32 g, 78.2 %): m.p. 332-335 °C. UV (DMF): 274
nm. IR (KBr, νmax, cm–1): 3400-3300 (phenolic OH and NH2),
2-[1′,4′-Dioxo-3′-hydrophthalazin-2′-yl]-7H-6-(2′-
hydroxynaphthalene)thiazolo[5,4-d]pyrazole (8):A mixture
of compound 3 (2.97 g, 0.01 mol) and phthalic anhydride (1.48
g, 0.01 mol) in glacial acetic acid (50 mL) refluxed for 4 h.
Cooled and then poured onto ice. The solid produced filtered
off and crystallized from DMF, to give compound 8, yield
(3.46 g, 85.2 %): m.p. 341-344 °C. IR (KBr, νmax, cm–1): 3400-
3300 (phenolic OH-NH), 1680 (C=O), 1556 (C=N), 1350 (NCS),
830 (substituted aryl). 1H NMR (DMSO-d6) δ (ppm): 12.9 (s,
1H, NH), 10.55 (s, 1H, OH), 8.8 (s, 1H α-C5H), 8.20-8.02, 7.89-
7.72, 7.70-7.65, 7.55-7.22 (each d 10H, aromatic). 13C NMR
(DMSO-d6) δ (ppm): 172, 166 (2C=O), 140 (C=N), 132-122
(aromatic carbons). M/S (Int. %): 428 (0.11), 276 (3.18), 161
(25.11), 217 (18,0), 143 (100), 152 (80). Analytical data for
C22H13N5O3S (427): Calcd.: C, 61.55; H, 3.04; N, 16.39; S,
7.49 %. Found: C, 61.55; H, 2.88; N, 16.15; S, 7.29 %.
(Z)-N-((Z)-1-(4′-Chlorophenyl)-3-(7′H-6′-(2′′-hydroxy-
naphthalen)thiazolo[5,4]pyrazol-2′-yl-hydrazinyl)-3-oxo-
prop-1-en-2-yl)benzimidic acid (10):A mixture of compound
3 (2.97 g, 0.01 mol) and oxazolinone (9) (2.84 g, 0.01 mol) in
aq. EtOH (100 mL) refluxed for 1 h. Cooled and then poured
onto ice. The solid obtained filtered off and crystallized from
DMF to give compound 10, yield (4.56 g, 78.5 %): m.p. 342-
346 °C. UV (DMF): 430 nm. IR (KBr, νmax, cm–1): 3462 (phenolic
OH), 2600 (alcoholic OH), 3150 (NH), 1662 (C=O), 1620 (C=C),
1579 (C=N), 831 (substituted aryl), 679 (C-Cl). Analytical
data for C30H20N6SO3 (544): Calcd.: C, 66.17; H, 3.67; N, 15.44;
S, 5.88 %. Found: C, 65.89; H, 3.51; N, 15.30; S, 5.55 %.
2-(3′-Phenyl-6′-oxo-5′-chlorobenzylidene-1′,2′-dihydro-
1,2,4-triazin-2′-yl)-7H-6-(2′-hydroxynaphthaline)thiazolo-
[5,4-d]pyrazole (11): Compound 10 (5.8 g, 0.01 mol) with
aq. K2CO3 (10 %, 50 mL) refluxed for 2 h. Cooled and then poured
onto ice-HCl. The solid produced filtered off and crystallized
from DMF, to give compound 11, yield (4.5 g, 81 %): m.p.
355-356 °C. UV (DMF): 420 nm. IR (KBr, νmax, cm–1): 3462
(phenolic OH), 3160 (NH), 1663 (C=O), 1579 (C=N), 1320
(NSC), 831 (substituted aryl) (C-Cl). 1HNMR(DMSO-d6) δ(ppm):
11.8 (s, 1H, NH), 10.55 (s, 1H, OH), 8.9 (s, 1H, exo CH=C),
8.55 (s, 1H α-C5H), 7.9-7.66 (m, 6H, naphthyl), 7.2-6.7 (m,
4H, phenyl).Analytical data for C30H19N6O2SCl(561): Calcd.:
C, 64.17; H, 3.38; N, 14.97; S, 5.70 Cl, 6.23 %. Found: C,
64.00; H, 3.20; N, 14.71; S, 5.39 Cl, 6.00 %.
1
1594 (C=N), 1359 (NCS), 817 (substituted aryl). H NMR
(DMSO-d6) δ (ppm): 10.55 (s, 1H, OH), 8.55 (s, 1H, α-C5H),
8.1 (s, 1H, C4 of pyrazole), 3.8-3.55 (4H, 2NH2), 7.70-7.10
(m, 6H, aromatic protons). Analytical data for C17H13N7OS
(366): Calcd.: C, 56.55; H, 3.55; N, 26.77; S, 8.74 %. Found:
C, 56.32; H, 3.25; N, 26.40; S, 8.52 %.
2-[3′,5′-Dioxo-2′,3′,4′,5′-tetrahydropyrazol-1′-yl]-7H-
6-(2′-hydroxynaphthalene)-thi-azolo[5,4-d]pyrazole (5):A
mixture of compound 3 (2.97 g, 0.01 mol) and malonic acid
(1.04 g, 0.01 mol) in glacial acetic acid (50 mL) refluxed for 4 h.
Cooled and then poured onto ice. The solid obtained filtered
off and crystallized from DMF, to give compound 5, yield
(3.16 g, 86.4 %): m.p. 334-337 °C. UV (DMF): 445 nm. IR
(KBr, νmax, cm–1): 3400-3200 (phenolic OH and NH), 1700-
1670 (2C=O), 1575 (C=N), 1466 (deformation CH2), 831
(substituted aryl). 1H NMR (DMSO-d6) δ (ppm): 13.14 (s, 1H,
NH), 10.82 (s, 1H, OH), 8.14 (s, 1H, α-C5H), 7.9-7.07 (m, 6H,
aromatic protons), 3.7-3.69 (m, 2H, CH2). 13C NMR (DMSO-d6)
δ (ppm): 161 (C=O), 134 (C=N), 128-118 (aromatic carbons),
108 (C-C) 40-39.13 (CH2). M/S (Int. %) 3.66 (1.11), 276
(15.9), 217 (5.6), 143 (100), 89 (12.11), 71 (5.1), 67 (23.0).
Analytical data for C17H11N5O3S (368): Calcd.: C, 56.25; H,
2.98; N, 19.02; S, 8.69 %. Found: C, 56.01; H, 2.70; N, 18.85;
S, 8.53 %.
2-[3′-Phenyl-5′-oxo-4′,5′-dihydropyrazol-1′-yl]-7H-6-
(2′-hydroxynaphthalene)thiazolo[5,4-d]pyrazole (6): A
mixture of compound 3 (2.97g, 0.01 mol) and ethyl benzoyl
acetate (1.92 g, 0.01 mol) in absolute EtOH (50 mL) with
piperidine (few drops) refluxed for 4 h. Cooled and then poured
onto ice. The solid obtained filtered off and crystallized from
DMF to give compound 6, yield (3.6 g, 79 %): m.p. 321-324 °C.
IR (KBr, νmax, cm–1): 3300 (phenolic OH), 1682 (C=O), 1595
(C=N), 1447 (deformation CH2), 817 (substituted aryl). 1H NMR
(DMSO-d6) δ (ppm): 10.3 (s, 1H, OH), 8.2 (s, 1H, α-C5H),
7.9-7.2 (m, 6H, aryl), 7.1-6.9 (m, 4H, phenyl), 4.0 (s, 2H,
CH2-C=O). Analytical data for C23H15N5O2S(425): Calcd.: C,
64.94; H, 3.52; N, 16.47; S, 7.52 %. Found: C, 64.71; H, 3.22;
N, 16.25; S, 7.33 %.
2-[3′,5′-Diphenyl-4′,5′-dihydropyrazol-1′-yl]-7H-6-(2′-
hydroxynaphthalene)thiazolo[5,4-d]pyrazole (7):A mixture
of compound 3 (2.97 g, 0.01 mol) and benzyl benzoyl acetate
(2.54 g, 0.01 mol) in absolute EtOH (50 mL) with piperidine
(few drops) refluxed for 4 h. Cooled and then poured onto ice.
The solid produced filtered off and crystallized from DMF to
give compound 7, yield (3.7 g, 76 %): m.p. 319-322 °C. UV
(DMF): 292 nm. IR (KBr, νmax, cm–1): 3010 (aromatic CH),
2939 (aliphatic CH), 1595 (C=N), 1447 (deformation CH2),
817.83 (substituted aryl). 1H NMR (DMSO-d6) δ (ppm): 10.1
(s, 1H, OH), 8.2 (s, 1H α-C5H), 8.04-7.25 (m, 16H, aromatic),
4.59 (d, 1H, C5-pyrazole), 2.8 (m, 2H, CH2).). 13C NMR (DMSO-
Biological evaluation (antibacterial activity): Rhodanine
structure contains hydrogen bond acceptor (A), hydrogen bond
donor (D), hydrophobic (H), positive ionic center (P), negative
ionic center (N). Also, rhodanine structure characterized by a
tautomer’s generating possible stereoisomers which generating
low energy ring conformations. Thus, rhodanine and its analogues
have a various pharmacological and biological activities.Based
upon these observation, we synthesized a novel heterobicyclic
nitrogen systems starting from rhodanine (1).
In search for new antibacterial agents, the present work,
report a new synthetic of possible targets. All the synthesized
compounds were evaluated as anti-bacterial agents, against